Recent posts

TypePostAuthorRepliesLast updated
Blog entrySCP24:WIPO patent committee adopts robust work program on patents and health, limitations and exceptions and quality of patents thiru08 hours 23 min ago
Blog entryUSPTO publishes new estimates of "IP-Intensive" industries, spin results James Love01 day 20 hours ago
PageAndrew S. Goldman, Counsel, Policy and Legal Affairs Claire Cassedy01 day 23 hours ago
Blog entryNational Association of Manufacturers told USTR the EU position on LDC extension made a mockery of international trading system thiru05 days 5 hours ago
Blog entryDifferences between the march-in, royalty free right, and government use options James Love05 days 19 hours ago
PageDiane Singhroy, Scientific and Technical Advisor Claire Cassedy01 week 3 hours ago
Blog entry500+ Pages of Documents on NFL Attempts to Influence NIH Funding of Concussion Studies Zack Struver01 week 1 day ago
Blog entryNIH Waivers for U.S. Manufacturing Requirements for Federally-Funded Drugs Zack Struver01 week 1 day ago
Blog entryKEI Statement on United Nations Secretary-General's High-Level Panel on Access to Medicines Report KEI Staff01 week 4 days ago
Blog entryCancer Moonshot Blue Ribbon Panel Does Not Address Pricing, Alternative Funding Models Zack Struver01 week 4 days ago
Blog entrySummary of Report of United Nations Secretary-General's High-Level Panel on Access to Medicines Zack Struver01 week 6 days ago
Blog entryTRIPS Council (October 2014): India calls for de-linkage and innovation inducement prizes at WTO discussions on IP & innovation thiru02 weeks 3 hours ago
Blog entryWIPO Marrakesh Treaty for the blind to come into force September 30, 2016, following ratification by Canada James Love02 weeks 4 days ago
Blog entryGerman Court Issues Compulsory License on HIV Drug Patent Andrew Goldman02 weeks 5 days ago
Blog entryCommentary on Hillary Clinton's Plan to Respond to Unjustified Price Hikes for Long-Available Drugs Claire Cassedy02 weeks 6 days ago
Blog entryKEI Briefing Note 2016:2: 2015-2016 Pharmaceutical Transparency Legislation Zack Struver03 weeks 1 day ago
Book pagePublications and Research Notes James Love03 weeks 1 day ago
Blog entry2016: KEI/MSF comments to NIH on licensing of patents on Attenuated Respiratory Syncytial Virus (RSV) Vaccines James Love04 weeks 5 days ago
Blog entryHarvoni & Sovaldi, Xtandi in Top 20 Costliest Medicare Drugs Zack Struver06 weeks 5 days ago
Blog entryBloomberg: CVS Will Exclude Xtandi From Formulary in 2017 Zack Struver08 weeks 21 hours ago
Blog entryVivendi-SFR lobbyist nominated to WIPO Staff08 weeks 23 hours ago
Blog entryProposal for a WTO Agreement on the Supply of Public goods KEI Staff08 weeks 4 days ago
Blog entryLetter from 56 non-profits and experts to Secretary of State John Kerry on pressure on global access to medicines initiatives Zack Struver08 weeks 6 days ago
Blog entryWIPO GA 2013 to decide on future of the Intergovernmental Committee on Genetic Resources, Traditional Knowledge and Folklore thiru08 weeks 6 days ago
Blog entryHuman Rights Council adopts watershed resolution on Access to Medicines thiru010 weeks 2 days ago